This assay is to provide LL/2-based In Vivo Tumorigenesis Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
LL/2
Target Cell Organism
Mouse
Target Cell Background
LL/2 (LLC1) is a cell line established from the lung of a C57BL mouse bearing a tumor resulting from an implantation of primary Lewis lung carcinoma.
Target Cell Alternative Name
LLC1
Related Diseases
Lewis Lung Carcinoma
Research Area
Oncology
Assay Name
In Vivo Tumorigenesis Assay
Short Description
LL/2-cell based In Vivo Tumorigenesis Assay
Assay Description
Tumorigenicity is defined the property of a cell to form tumors when inoculated into an immunosuppressed animal model. Generally, test cells and tumor cells as positive control are administered subcutaneously into immunosuppressed nude mice. The number of animals developing tumors are compared with a positive control reference cell line.